CalMustang, so FDA took the Adcom route after Amarin withdrew the FOIA requests just to keep Amarin under their thumbs. But what made Amarin to withdraw FOIA requests? Something promised during the label negotiations. Then once withdrew, FDA came up with the Adcom whip just to keep Amarin under check, imo. Why the 9/28 PDUFA date hasn't been changed yet by FDA? Looks to me Conditional Approval by 9/28 is in the cards. Post Approval Adcom after Dec 5th to iron out Label Changes, imo.